Piflufolastat F-18 injection drugs (PYLARIFY) from sofie CO. [pots 25-000073]
Ended Awarded Last action
- Contract number
- 75N90025F00003
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $223,967
Award facts
- Contract value 100% obligated
- $223,966.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of PYLARIFY (piflufolastat F-18) injection drugs from Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract, awarded by the National Institutes of Health (NIH) Clinical Center, is a firm fixed price delivery order with a ceiling value of $223,966.80. The contract is not set aside and is primarily for the supply of PYLARIFY, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. Progenics Pharmaceuticals holds several significant federal contract Indefinite Delivery Vehicles (IDVs), including Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs (VA) and Defense Health Agency (DHA), which facilitate the ongoing procurement of PYLARIFY and other radiopharmaceuticals for government healthcare programs.
Quick answers
Who was awarded contract 75N90025F00003?
75N90025F00003 was awarded to Progenics Pharmaceuticals Inc. by NIH Clinical Center (National Institutes of Health) on October 1, 2024.
How much is contract 75N90025F00003 worth?
The government has obligated $223,967 on 75N90025F00003.
Is contract 75N90025F00003 an order under another contract?
Yes. 75N90025F00003 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75N90025F00003 competed?
The extent of competition for 75N90025F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award